nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.00209	0.00209	CcSEcCtD
Polythiazide—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.00208	0.00208	CcSEcCtD
Polythiazide—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Polythiazide—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00204	0.00204	CcSEcCtD
Polythiazide—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00204	0.00204	CcSEcCtD
Polythiazide—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.00203	0.00203	CcSEcCtD
Polythiazide—Anorexia—Glipizide—type 2 diabetes mellitus	0.00203	0.00203	CcSEcCtD
Polythiazide—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00202	0.00202	CcSEcCtD
Polythiazide—Rash—Tolazamide—type 2 diabetes mellitus	0.00202	0.00202	CcSEcCtD
Polythiazide—Agitation—Bromocriptine—type 2 diabetes mellitus	0.00202	0.00202	CcSEcCtD
Polythiazide—Headache—Tolazamide—type 2 diabetes mellitus	0.00201	0.00201	CcSEcCtD
Polythiazide—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00201	0.00201	CcSEcCtD
Polythiazide—Cramp muscle—Losartan—type 2 diabetes mellitus	0.002	0.002	CcSEcCtD
Polythiazide—Pancreatitis—Irbesartan—type 2 diabetes mellitus	0.002	0.002	CcSEcCtD
Polythiazide—Rash—Linagliptin—type 2 diabetes mellitus	0.002	0.002	CcSEcCtD
Polythiazide—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.002	0.002	CcSEcCtD
Polythiazide—Headache—Linagliptin—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Polythiazide—Purpura—Ramipril—type 2 diabetes mellitus	0.00198	0.00198	CcSEcCtD
Polythiazide—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.00197	0.00197	CcSEcCtD
Polythiazide—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00197	0.00197	CcSEcCtD
Polythiazide—Vomiting—Acarbose—type 2 diabetes mellitus	0.00196	0.00196	CcSEcCtD
Polythiazide—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.00195	0.00195	CcSEcCtD
Polythiazide—Rash—Acarbose—type 2 diabetes mellitus	0.00195	0.00195	CcSEcCtD
Polythiazide—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00194	0.00194	CcSEcCtD
Polythiazide—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00193	0.00193	CcSEcCtD
Polythiazide—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.00191	0.00191	CcSEcCtD
Polythiazide—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00191	0.00191	CcSEcCtD
Polythiazide—Nausea—Tolazamide—type 2 diabetes mellitus	0.00191	0.00191	CcSEcCtD
Polythiazide—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.0019	0.0019	CcSEcCtD
Polythiazide—Anorexia—Glimepiride—type 2 diabetes mellitus	0.00189	0.00189	CcSEcCtD
Polythiazide—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00189	0.00189	CcSEcCtD
Polythiazide—Pancreatitis—Losartan—type 2 diabetes mellitus	0.00189	0.00189	CcSEcCtD
Polythiazide—Rash—Nateglinide—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Polythiazide—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00187	0.00187	CcSEcCtD
Polythiazide—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.00187	0.00187	CcSEcCtD
Polythiazide—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.00185	0.00185	CcSEcCtD
Polythiazide—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.00184	0.00184	CcSEcCtD
Polythiazide—Nausea—Acarbose—type 2 diabetes mellitus	0.00183	0.00183	CcSEcCtD
Polythiazide—Constipation—Glipizide—type 2 diabetes mellitus	0.00182	0.00182	CcSEcCtD
Polythiazide—Leukopenia—Glyburide—type 2 diabetes mellitus	0.0018	0.0018	CcSEcCtD
Polythiazide—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.00178	0.00178	CcSEcCtD
Polythiazide—Jaundice—Irbesartan—type 2 diabetes mellitus	0.00178	0.00178	CcSEcCtD
Polythiazide—Nausea—Nateglinide—type 2 diabetes mellitus	0.00177	0.00177	CcSEcCtD
Polythiazide—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Polythiazide—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Polythiazide—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00175	0.00175	CcSEcCtD
Polythiazide—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Polythiazide—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Polythiazide—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.00173	0.00173	CcSEcCtD
Polythiazide—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.00172	0.00172	CcSEcCtD
Polythiazide—Cramp muscle—Ramipril—type 2 diabetes mellitus	0.00172	0.00172	CcSEcCtD
Polythiazide—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.00171	0.00171	CcSEcCtD
Polythiazide—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Polythiazide—Constipation—Sitagliptin—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Polythiazide—Urticaria—Glipizide—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Polythiazide—Jaundice—Losartan—type 2 diabetes mellitus	0.00167	0.00167	CcSEcCtD
Polythiazide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Polythiazide—Agitation—Gliclazide—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Polythiazide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Polythiazide—Rash—Repaglinide—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Polythiazide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Polythiazide—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Polythiazide—Pancreatitis—Ramipril—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Polythiazide—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Polythiazide—Headache—Repaglinide—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Polythiazide—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Polythiazide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Polythiazide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Polythiazide—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Polythiazide—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Polythiazide—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Polythiazide—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Polythiazide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Polythiazide—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Polythiazide—Anorexia—Glyburide—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Polythiazide—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Polythiazide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Polythiazide—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Polythiazide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Polythiazide—Nausea—Repaglinide—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Polythiazide—Asthenia—Glipizide—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Polythiazide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Polythiazide—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Polythiazide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Polythiazide—Vertigo—Valsartan—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Polythiazide—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Polythiazide—Vertigo—Orlistat—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Polythiazide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Polythiazide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Polythiazide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Polythiazide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Polythiazide—Muscle spasms—Metformin—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Polythiazide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Polythiazide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Polythiazide—Jaundice—Ramipril—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Polythiazide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Polythiazide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Polythiazide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Polythiazide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Polythiazide—Dizziness—Glipizide—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Polythiazide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Polythiazide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Polythiazide—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Polythiazide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Polythiazide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Polythiazide—Vomiting—Glipizide—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Polythiazide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Polythiazide—Rash—Glipizide—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Polythiazide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Polythiazide—Headache—Glipizide—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Polythiazide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Polythiazide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Polythiazide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Polythiazide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Polythiazide—Agitation—Irbesartan—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Polythiazide—Urticaria—Glyburide—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Polythiazide—Anorexia—Valsartan—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Polythiazide—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Polythiazide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Polythiazide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Polythiazide—Headache—Pioglitazone—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Polythiazide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Polythiazide—Nausea—Glipizide—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Polythiazide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Polythiazide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Polythiazide—Constipation—Gliclazide—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Polythiazide—Rash—Glimepiride—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Polythiazide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Polythiazide—Rash—Sitagliptin—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Polythiazide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Polythiazide—Headache—Glimepiride—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Polythiazide—Headache—Sitagliptin—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Polythiazide—Agitation—Losartan—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Polythiazide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Polythiazide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Polythiazide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Polythiazide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Polythiazide—Vertigo—Losartan—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Polythiazide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Polythiazide—Leukopenia—Losartan—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Polythiazide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Polythiazide—Nausea—Glimepiride—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Polythiazide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Polythiazide—Asthenia—Glyburide—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Polythiazide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Polythiazide—Anorexia—Metformin—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Polythiazide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Polythiazide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Polythiazide—Constipation—Valsartan—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Polythiazide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Polythiazide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Polythiazide—Rash—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Polythiazide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Polythiazide—Headache—Bromocriptine—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Polythiazide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Polythiazide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Polythiazide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Polythiazide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Polythiazide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00108	0.00108	CcSEcCtD
Polythiazide—Urticaria—Valsartan—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Polythiazide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Polythiazide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Polythiazide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Polythiazide—Urticaria—Orlistat—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Polythiazide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Polythiazide—Agitation—Ramipril—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Polythiazide—Constipation—Metformin—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Polythiazide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Polythiazide—Anorexia—Losartan—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Polythiazide—Vomiting—Glyburide—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Polythiazide—Rash—Glyburide—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Polythiazide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Polythiazide—Vertigo—Ramipril—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Polythiazide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Polythiazide—Headache—Glyburide—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Polythiazide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Polythiazide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Polythiazide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000996	0.000996	CcSEcCtD
Polythiazide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000994	0.000994	CcSEcCtD
Polythiazide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000985	0.000985	CcSEcCtD
Polythiazide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000982	0.000982	CcSEcCtD
Polythiazide—Urticaria—Metformin—type 2 diabetes mellitus	0.000978	0.000978	CcSEcCtD
Polythiazide—Nausea—Glyburide—type 2 diabetes mellitus	0.000974	0.000974	CcSEcCtD
Polythiazide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000973	0.000973	CcSEcCtD
Polythiazide—Asthenia—Valsartan—type 2 diabetes mellitus	0.00097	0.00097	CcSEcCtD
Polythiazide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000959	0.000959	CcSEcCtD
Polythiazide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000951	0.000951	CcSEcCtD
Polythiazide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000936	0.000936	CcSEcCtD
Polythiazide—Constipation—Losartan—type 2 diabetes mellitus	0.000935	0.000935	CcSEcCtD
Polythiazide—Rash—Gliclazide—type 2 diabetes mellitus	0.000928	0.000928	CcSEcCtD
Polythiazide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000927	0.000927	CcSEcCtD
Polythiazide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000925	0.000925	CcSEcCtD
Polythiazide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000923	0.000923	CcSEcCtD
Polythiazide—Headache—Gliclazide—type 2 diabetes mellitus	0.000922	0.000922	CcSEcCtD
Polythiazide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000918	0.000918	CcSEcCtD
Polythiazide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000914	0.000914	CcSEcCtD
Polythiazide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000894	0.000894	CcSEcCtD
Polythiazide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000894	0.000894	CcSEcCtD
Polythiazide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000884	0.000884	CcSEcCtD
Polythiazide—Asthenia—Metformin—type 2 diabetes mellitus	0.000884	0.000884	CcSEcCtD
Polythiazide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000874	0.000874	CcSEcCtD
Polythiazide—Urticaria—Losartan—type 2 diabetes mellitus	0.000869	0.000869	CcSEcCtD
Polythiazide—Vomiting—Valsartan—type 2 diabetes mellitus	0.00086	0.00086	CcSEcCtD
Polythiazide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000856	0.000856	CcSEcCtD
Polythiazide—Rash—Valsartan—type 2 diabetes mellitus	0.000853	0.000853	CcSEcCtD
Polythiazide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000852	0.000852	CcSEcCtD
Polythiazide—Vomiting—Orlistat—type 2 diabetes mellitus	0.00085	0.00085	CcSEcCtD
Polythiazide—Headache—Valsartan—type 2 diabetes mellitus	0.000847	0.000847	CcSEcCtD
Polythiazide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000843	0.000843	CcSEcCtD
Polythiazide—Rash—Orlistat—type 2 diabetes mellitus	0.000843	0.000843	CcSEcCtD
Polythiazide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000842	0.000842	CcSEcCtD
Polythiazide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000842	0.000842	CcSEcCtD
Polythiazide—Headache—Orlistat—type 2 diabetes mellitus	0.000837	0.000837	CcSEcCtD
Polythiazide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000834	0.000834	CcSEcCtD
Polythiazide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000815	0.000815	CcSEcCtD
Polythiazide—Dizziness—Metformin—type 2 diabetes mellitus	0.000814	0.000814	CcSEcCtD
Polythiazide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000806	0.000806	CcSEcCtD
Polythiazide—Nausea—Valsartan—type 2 diabetes mellitus	0.000803	0.000803	CcSEcCtD
Polythiazide—Constipation—Ramipril—type 2 diabetes mellitus	0.000802	0.000802	CcSEcCtD
Polythiazide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000795	0.000795	CcSEcCtD
Polythiazide—Nausea—Orlistat—type 2 diabetes mellitus	0.000794	0.000794	CcSEcCtD
Polythiazide—Asthenia—Losartan—type 2 diabetes mellitus	0.000785	0.000785	CcSEcCtD
Polythiazide—Vomiting—Metformin—type 2 diabetes mellitus	0.000783	0.000783	CcSEcCtD
Polythiazide—Rash—Metformin—type 2 diabetes mellitus	0.000777	0.000777	CcSEcCtD
Polythiazide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000776	0.000776	CcSEcCtD
Polythiazide—Headache—Metformin—type 2 diabetes mellitus	0.000772	0.000772	CcSEcCtD
Polythiazide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000769	0.000769	CcSEcCtD
Polythiazide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000748	0.000748	CcSEcCtD
Polythiazide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000745	0.000745	CcSEcCtD
Polythiazide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000739	0.000739	CcSEcCtD
Polythiazide—Rash—Irbesartan—type 2 diabetes mellitus	0.000733	0.000733	CcSEcCtD
Polythiazide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000732	0.000732	CcSEcCtD
Polythiazide—Nausea—Metformin—type 2 diabetes mellitus	0.000732	0.000732	CcSEcCtD
Polythiazide—Headache—Irbesartan—type 2 diabetes mellitus	0.000728	0.000728	CcSEcCtD
Polythiazide—Dizziness—Losartan—type 2 diabetes mellitus	0.000723	0.000723	CcSEcCtD
Polythiazide—Vomiting—Losartan—type 2 diabetes mellitus	0.000695	0.000695	CcSEcCtD
Polythiazide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000691	0.000691	CcSEcCtD
Polythiazide—Nausea—Irbesartan—type 2 diabetes mellitus	0.00069	0.00069	CcSEcCtD
Polythiazide—Rash—Losartan—type 2 diabetes mellitus	0.00069	0.00069	CcSEcCtD
Polythiazide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000689	0.000689	CcSEcCtD
Polythiazide—Headache—Losartan—type 2 diabetes mellitus	0.000685	0.000685	CcSEcCtD
Polythiazide—Asthenia—Ramipril—type 2 diabetes mellitus	0.000673	0.000673	CcSEcCtD
Polythiazide—Nausea—Losartan—type 2 diabetes mellitus	0.00065	0.00065	CcSEcCtD
Polythiazide—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000642	0.000642	CcSEcCtD
Polythiazide—Dizziness—Ramipril—type 2 diabetes mellitus	0.00062	0.00062	CcSEcCtD
Polythiazide—Vomiting—Ramipril—type 2 diabetes mellitus	0.000596	0.000596	CcSEcCtD
Polythiazide—Rash—Ramipril—type 2 diabetes mellitus	0.000591	0.000591	CcSEcCtD
Polythiazide—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000591	0.000591	CcSEcCtD
Polythiazide—Headache—Ramipril—type 2 diabetes mellitus	0.000588	0.000588	CcSEcCtD
Polythiazide—Nausea—Ramipril—type 2 diabetes mellitus	0.000557	0.000557	CcSEcCtD
